A hypothalamic VMPO-supraoptic vasopressin circuit mediates procalcitonin-induced fluid imbalance.

Summary

This mechanistic study shows that systemic procalcitonin crosses the blood-brain barrier and activates calcitonin receptors on Oprk1+ neurons in the hypothalamic VMPO, engaging a VMPO–supraoptic vasopressin circuit that perturbs fluid homeostasis. The work reframes PCT from a passive biomarker to an active mediator of dysnatremia and fluid imbalance in sepsis.

Key Findings

• Systemic procalcitonin traverses the blood-brain barrier.
• Procalcitonin activates calcitonin receptors and depolarizes Oprk1-expressing VMPO neurons.
• A VMPO–supraoptic nucleus vasopressin circuit mediates PCT-induced disruption of fluid homeostasis.

Clinical Implications

Reconceptualizes PCT as a potential driver of dysnatremia/volume derangements; suggests that antagonizing calcitonin-receptor signaling or modulating VMPO–vasopressin circuits might mitigate fluid imbalance in sepsis. Also cautions that exogenous PCT dynamics could have physiological effects.

Limitations

• Preclinical mechanistic work; human translational validation not detailed in the abstract
• Magnitude and temporal dynamics of PCT effects in clinical sepsis remain to be quantified

Future Directions

Validate the VMPO–vasopressin pathway in human sepsis, test calcitonin-receptor antagonists or neuromodulation strategies, and quantify PCT–osmoregulation dynamics in vivo.